Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Shares Outstanding (Diluted Average) (2016 - 2025)

Haemonetics has reported Shares Outstanding (Diluted Average) over the past 17 years, most recently at $47.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $47.7 million for Q4 2025, down 6.8% from a year ago — trailing twelve months through Dec 2025 was $47.7 million (down 6.8% YoY), and the annual figure for FY2025 was $50.7 million, down 1.3%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $47.7 million at Haemonetics, roughly flat from $47.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for HAE hit a ceiling of $51.7 million in Q3 2022 and a floor of $47.7 million in Q3 2025.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $51.4 million (2022), compared with a mean of $50.8 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 1.46% in 2022 and later decreased 7.27% in 2025.
  • Haemonetics' Shares Outstanding (Diluted Average) stood at $51.4 million in 2021, then dropped by 0.27% to $51.2 million in 2022, then increased by 0.44% to $51.4 million in 2023, then dropped by 0.58% to $51.1 million in 2024, then decreased by 6.8% to $47.7 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $47.7 million (Q4 2025), $47.7 million (Q3 2025), and $48.4 million (Q2 2025) per Business Quant data.